Effects of Degranol on Tumor Nucleic Acid Metabolism
Author Information
Author(s): E. J. Hidvegi, F. Antoni, K. Lapis
Primary Institution: Institute of Biochemistry, Medical University, Budapest, Hungary
Hypothesis
How does Degranol affect the incorporation of 32p into nucleic acids in tumors?
Conclusion
Degranol decreases the incorporation of 32p into nucleic acids in tumors, with the most significant effect on DNA.
Supporting Evidence
- Degranol caused a significant decrease in DNA incorporation of 32p, with more than 50% reduction in 24 hours.
- At 72 hours, the decrease in DNA incorporation was most marked, while nRNA and cRNA showed less reduction.
- By 96 hours, the incorporation levels of all nucleic acids returned to control levels.
Takeaway
Degranol is a drug that helps fight tumors by changing how tumor cells use important building blocks called nucleic acids.
Methodology
Inbred albino rats with Guerin carcinoma were treated with Degranol and the incorporation of 32p into nucleic acids was measured at various time points.
Limitations
The study was conducted on a specific type of tumor in rats, which may not fully represent human tumors.
Participant Demographics
Inbred albino rats weighing 120 to 150 g.
Want to read the original?
Access the complete publication on the publisher's website